Triple
T412173
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | National Institute on Drug Abuse |
E9512
|
entity |
| Predicate | operates |
P24
|
FINISHED |
| Object |
NIDA Clinical Trials Network
The NIDA Clinical Trials Network is a nationwide research infrastructure that conducts multi-site clinical studies to develop, test, and disseminate evidence-based treatments for substance use disorders.
|
E9512
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NIDA Clinical Trials Network | Statement: [National Institute on Drug Abuse, operates, NIDA Clinical Trials Network]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NIDA Clinical Trials Network Context triple: [National Institute on Drug Abuse, operates, NIDA Clinical Trials Network]
-
A.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
B.
National Institute of Neurological Disorders and Stroke
The National Institute of Neurological Disorders and Stroke is a U.S. government research agency that supports and conducts scientific studies on the brain and nervous system to better understand, treat, and prevent neurological disorders.
-
C.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
D.
National Institute of Nursing Research
The National Institute of Nursing Research is a U.S. federal agency that supports and conducts clinical and basic research to improve health outcomes through nursing science.
-
E.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: NIDA Clinical Trials Network Triple: [National Institute on Drug Abuse, operates, NIDA Clinical Trials Network]
Generated description
The NIDA Clinical Trials Network is a nationwide research infrastructure that conducts multi-site clinical studies to develop, test, and disseminate evidence-based treatments for substance use disorders.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: NIDA Clinical Trials Network Target entity description: The NIDA Clinical Trials Network is a nationwide research infrastructure that conducts multi-site clinical studies to develop, test, and disseminate evidence-based treatments for substance use disorders.
-
A.
National Institute on Drug Abuse
chosen
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
B.
National Institute of Neurological Disorders and Stroke
The National Institute of Neurological Disorders and Stroke is a U.S. government research agency that supports and conducts scientific studies on the brain and nervous system to better understand, treat, and prevent neurological disorders.
-
C.
National Center for Advancing Translational Sciences
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
-
D.
National Institute of Nursing Research
The National Institute of Nursing Research is a U.S. federal agency that supports and conducts clinical and basic research to improve health outcomes through nursing science.
-
E.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences is a U.S. government biomedical research institute that supports fundamental, non-disease-specific science and training to advance understanding of biological processes and lay the groundwork for medical advances.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a2e80111fc8190961d5b7c6154123f |
completed | Feb. 28, 2026, 1:05 p.m. |
| NER | Named-entity recognition | batch_69a2ecdafa2481908111accc918ff2e8 |
completed | Feb. 28, 2026, 1:25 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a423a152b0819099cfb9dd799ce755 |
completed | March 1, 2026, 11:31 a.m. |
| NEDg | Description generation | batch_69a423fc21188190bacc03bfae9ac401 |
completed | March 1, 2026, 11:33 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a42486e1e08190b7603c34d625da7c |
completed | March 1, 2026, 11:35 a.m. |
Created at: Feb. 28, 2026, 1:09 p.m.